Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1795087 Target Snapshot

Ubiquitin carboxyl-terminal hydrolase 1 · SINGLE PROTEIN · Homo sapiens

23,294Compounds
42Assays
1Approved Drugs
1,787.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O94782. Use UniProt O94782 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O94782 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Ubiquitin carboxyl-terminal hydrolase 1 as ChEMBL target CHEMBL1795087, mapped to UniProt O94782. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Ubiquitin carboxyl-terminal hydrolase 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1795087
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O94782
Ubiquitin carboxyl-terminal hydrolase 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Ubiquitin carboxyl-terminal hydrolase 1 is the right protein anchor across sources, using UniProt O94782 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUbiquitin carboxyl-terminal hydrolase 1
UniProt AccessionO94782
Component TypeProtein
Sequence Length785 aa

Ubiquitin carboxyl-terminal hydrolase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Ubiquitin carboxyl-terminal hydrolase 1, mapped to UniProt O94782. Sequence length is 785 aa.

Mapped IDO94782
Review nameUbiquitin carboxyl-terminal hydrolase 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC501,786.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5558715 8.39 IC50 4.1 Preclinical
CHEMBL5095186 7.96 IC50 11.0 Preclinical
CHEMBL1232461 7.52 Kd 30.0 Clinical
CHEMBL5740733 7.26 IC50 55.0 Preclinical
CHEMBL5743502 7.26 IC50 55.0 Preclinical
CHEMBL5745516 7.26 IC50 55.0 Preclinical
CHEMBL5745757 7.26 IC50 55.0 Preclinical
CHEMBL5748129 7.26 IC50 55.0 Preclinical
CHEMBL5748145 7.26 IC50 55.0 Preclinical
CHEMBL5755036 7.26 IC50 55.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
252
5.5
3
6.0
405
6.5
86
7.0
2
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

42
Total Assays
546
Tested Compounds
2
Assay Types
Binding — 37 assays, 546 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 29 544 6.6
cell-based format 7 1 7.1
assay format 1 1 8.4
Functional — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine